RYAH Group’s (CSE: RYAH) wholly owned subsidiary, RYAH Medtech Inc., a medical device, data and technology company, today announced its entry into a definitive wholesale supply and distribution agreement with Medical Kiwi Ltd, a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices. The newly formed agreement, executed on April 5, 2021, implies distribution of the RYAH Smart Inhaler and cloud-based data analytics platform in New Zealand. “Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner, CEO of RYAH Group Inc. and RYAH Medtech Inc. “In December 2019, the New Zealand Government passed legislation to improve access to medical cannabis products. Our new relationship with Medical Kiwi presents an opportunity for both parties to drive innovation and to deliver cutting-edge plant-based medical solutions in New Zealand.”
To view the full press release, visit https://cnw.fm/hz7kU
About RYAH Group Inc.
RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (”LPs”) to monitor and manage formulation effects on patients and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information about the company, please visit www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CanadianCannabisWire.com
Do you have a questions or are you interested in working with CNW? Ask our Editor